Follicular dendritic cell sarcoma treated with a variety of chemotherapy.

about

Follicular dendritic cell sarcoma treated with a variety of chemotherapy.

Item

http://www.wikidata.org/entity/Q49374551

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Follicular dendritic cell sarcoma treated with a variety of chemotherapy.

@en

Follicular dendritic cell sarcoma treated with a variety of chemotherapy.

@nl

type

Item

label

Follicular dendritic cell sarcoma treated with a variety of chemotherapy.

@en

Follicular dendritic cell sarcoma treated with a variety of chemotherapy.

@nl

prefLabel

Follicular dendritic cell sarcoma treated with a variety of chemotherapy.

@en

Follicular dendritic cell sarcoma treated with a variety of chemotherapy.

@nl

P1476

Follicular dendritic cell sarcoma treated with a variety of chemotherapy.

@en

P2093

Ako Hosono

http://www.w3.org/2001/XMLSchema#string

Hiroaki Izumi

http://www.w3.org/2001/XMLSchema#string

Masaoki Sasaki

http://www.w3.org/2001/XMLSchema#string

Motohiro Kojima

http://www.w3.org/2001/XMLSchema#string

Takaaki Yokoyama

http://www.w3.org/2001/XMLSchema#string

P2860

Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma.

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Spontaneous regression of follicular dendritic cell sarcoma.

Clinicopathologic characteristics and outcomes of histiocytic and dendritic cell neoplasms: the moffitt cancer center experience over the last twenty five years.

Follicular dendritic cell sarcoma: a report of 14 cases and a review of the literature.

Follicular dendritic cell sarcoma: a case report and review of the literature.

Dendritic cell sarcoma: a pooled analysis including 462 cases with presentation of our case series.

P304

905-908

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1002/HON.2364

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27734516

http://www.w3.org/2001/XMLSchema#string

P932

5763378

http://www.w3.org/2001/XMLSchema#string